Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Interim Dividend

20 Dec 2021 15:09

RNS Number : 2455W
Aberdeen Latin American Inc Fd Ltd
20 December 2021
 

Aberdeen Latin American Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

20 December 2021

 

First Interim Dividend

In accordance with the Company's stated aim to pay a minimum dividend of 3.5p pence per share for the year, the Board of Aberdeen Latin American Income Fund Limited (the "Company") has today declared a first interim dividend of 0.875p per Ordinary share (2021: 0.875p) in respect of the year ending 31 August 2022 payable on 28 January 2022 to Ordinary shareholders on the register at close of business on 7 January 2022 (ex-dividend date 6 January 2022).

The Board is aware of the importance of income to the Company's shareholders and has maintained the dividend at the same rate as last year.

The Board continually assesses the impact on earnings resulting from the ongoing Covid-19 pandemic. Latin American governments continue to try to manage the effect of Covid-19 on their economies and our investee companies are seeking to manage volatile trading conditions as inflationary pressures mount. The Directors have previously noted the revenue reserve that has been built up and one of the benefits of the investment company structure is the ability to use accumulated reserves to maintain distributions to shareholders where there is a shortfall in earnings.

The Board's intention is that interim dividends will continue to be paid quarterly, subject to cash levels and reserves being sufficient to allow the Company to do so. The Directors place great emphasis on exercising prudence, particularly in these uncertain times, and on ensuring that the robustness of the Company's balance sheet is maintained. The Board continues to monitor closely the ongoing impact of Covid-19 and its variants and the success of the vaccine roll-out, together with its ramifications for the region, valuations and recurring earnings, while taking into account the income requirements of its shareholders, and will keep future dividend policy under review. 

abrdn Capital International Limited

Manager and Company Secretary

 

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBUBDDIGDDGBG
Date   Source Headline
13th Jun 20236:00 pmRNSAbrdn Latin American Income Fund
12th Jun 20231:05 pmRNSResult of EGM
12th Jun 20237:30 amRNSSuspension-abrdn Latin American Income Fund
9th Jun 202312:35 pmRNSNet Asset Value(s)
9th Jun 202310:33 amRNSRepayment and Cancellation of Loan Facility
8th Jun 202312:45 pmRNSNet Asset Value(s)
7th Jun 20234:46 pmRNSHolding(s) in Company
7th Jun 202312:01 pmRNSNet Asset Value(s)
7th Jun 202310:55 amRNSMonth End Net Asset Value(s)
6th Jun 202312:13 pmRNSNet Asset Value(s)
5th Jun 20234:18 pmRNSNet Asset Value(s)
2nd Jun 20233:39 pmRNSQuarterly disclosure
2nd Jun 20231:22 pmRNSNet Asset Value(s)
31st May 20231:28 pmRNSNet Asset Value(s)
30th May 20233:54 pmRNSGearing disclosure
30th May 20233:47 pmRNSHolding(s) in Company
30th May 202312:51 pmRNSNet Asset Value(s)
26th May 202312:38 pmRNSNet Asset Value(s)
25th May 20233:55 pmRNSHolding(s) in Company
25th May 202312:34 pmRNSNet Asset Value(s)
24th May 202311:59 amRNSNet Asset Value(s)
23rd May 202312:21 pmRNSNet Asset Value(s)
22nd May 20233:21 pmRNSGearing disclosure
22nd May 202312:25 pmRNSNet Asset Value(s)
19th May 20231:49 pmRNSNet Asset Value(s)
18th May 202312:50 pmRNSNet Asset Value(s)
18th May 202310:14 amRNSPortfolio disclosure
18th May 20237:00 amRNSRecommended Proposals for Winding-Up of Company
17th May 202312:37 pmRNSNet Asset Value(s)
16th May 202312:06 pmRNSNet Asset Value(s)
15th May 20232:55 pmRNSGearing disclosure
15th May 202311:41 amRNSNet Asset Value(s)
12th May 202312:14 pmRNSNet Asset Value(s)
11th May 202312:35 pmRNSNet Asset Value(s)
11th May 202311:57 amRNSHolding(s) in Company
10th May 20231:07 pmRNSNet Asset Value(s)
9th May 20235:38 pmRNSGearing disclosure
9th May 202311:53 amRNSNet Asset Value(s)
5th May 20236:15 pmRNSMonth End Net Asset Value(s)
5th May 20231:12 pmRNSNet Asset Value(s)
4th May 202312:36 pmRNSNet Asset Value(s)
3rd May 202312:44 pmRNSNet Asset Value(s)
2nd May 20234:05 pmRNSGearing disclosure
28th Apr 20231:00 pmRNSNet Asset Value(s)
27th Apr 20231:17 pmRNSNet Asset Value(s)
26th Apr 20231:12 pmRNSNet Asset Value(s)
25th Apr 202312:45 pmRNSNet Asset Value(s)
24th Apr 20232:26 pmRNSGearing disclosure
24th Apr 202312:19 pmRNSNet Asset Value(s)
21st Apr 202312:58 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.